Jon Tobias

Rheumatology Unit, Bristol Royal Infirmary, United Kingdom

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Diabetes & Endocrinology > Bone & Mineral Metabolism (since 21 August 2007)

All recent recommendations

• 6.0
  Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.
  Recommended by Jon Tobias with Emma Clark
  
• 9.0
  Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study.
  Recommended by Jon Tobias with Emma Clark
  
• 6.5
  Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
  Recommended by Jon Tobias, Peter Taylor with Dr. Sonya Abraham, Rene Rizzoli
  
• 9.0
  Zoledronic acid and clinical fractures and mortality after hip fracture.
  Recommended by Jon Tobias